2,4,6-Trichloropyrimidin-5-ol, 5g

N,N'-Di-Boc-guanidine, 99.0%, 250mg

1-(2-Bromo-6-fluorophenyl)-3-(2-methoxy-5-(trifluoromethyl)phenyl)urea, 97%, 50mg

(4-Amino-2-methylphenyl)methanol, 95.0%, 100mg

4-Fluoro-2-methyl-1H-indol-5-amine, 98.0%, 25g

2,3-Dihydroxynaphthalene>98.0%(GC)(T)25g

DBD-COCl [=4-(N,N-Dimethylaminosulfonyl)-7-(N-chloroformylmethyl-N-methylamino)-2,1,3-benzoxadiazole] [for HPLC Labeling]>93.0%(T)100mg

2-(4-Chlorobenzyl)-4,4,5,5-tetramethyl-1,3,2-dioxaborolane, 95.0%, 250mg

2-(N-(2-METHOXYETHYL)PHENYLSULFONAMIDO)ACETIC ACID, 95.0%, 250mg

(4-Formyl-5-hydroxy-6-methylpyridin-3-yl)methyl dihydrogen phosphate hydrate, 98.0%, 10g

4-Bromo-2-(dimethylamino)benzaldehyde, 98%, 1g

Methyl 3-amino-2-methoxyisonicotinate, 95.0%, 1g

6-hydrazinoimidazo[1,2-b]pyridazine, 95.0%, 1g